Cerebrospinal fluid levels of α-tocopherol and neopterin in patients with dementia

Pteridines

Volumn 10, Issue 4, 1999, Pages 220-224

  Sattler, Wolfgang ^a   Leblhuber, Friedrich ^b   Walli, Johannes ^b   Widner, Bernhard ^c   Fuchs, Dietmar ^c,d  

^a UNIVERSITY OF GRAZ   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d NONE   (Austria)

Author keywords

Alzheimer type dementia; Dementia; Neopterin; Oxidative stress; tocopherol

Indexed keywords

ALPHA TOCOPHEROL; GAMMA INTERFERON; NEOPTERIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; MONOCYTE; NERVE CELL NECROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SERUM;

EID: 0033497136     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.1999.10.4.220     Document Type: Article

References (22)

1. Geldmacher DS and Whitehouse PJ, Evaluation of dementias, New Engl. J. Med. 335: 30-36, 1996.
2. Beal MF, Aging, energy, and oxidative stress in neurodegenerative disease, Ann. Neurol. 38: 357-366, 1995.
3. Jenner P, Oxidative damage in neurodegenerative disease, Lancet 344: 796-798, 1994.
4. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME and Fontana A, On the cellular source and function of interleukin-6 produced in the central nervous system, Eur. J. Immunol. 19: 689-694, 1989.
5. Mooradian AD, Reed RL and Scuderi P, Serum levels of tumor necrosis factor alpha, interleukin-1 alpha and beta in healthy elderly subjects, Age 14: 61-64, 1991.
6. Fuchs D, Weiss, G and Wachter H, Neopterin, biochemistry and clinical use as a marker for cellular immune reactions, Int. Arch. Allergy Immunol. 101: 1-6, 1993.
7. Widner B, Baier-Bitterlich G, Wede I, Wirleitner B, Wachter H and Fuchs D, Neopterin: Indicator of oxidative stress and part of the cytotoxic armature of activated macrophages in humans. Pteridines 9: 91-102, 1998.
8. 2-induced luminol chemiluminescence: mechanistic aspects, Free Radical Biol. Med. 21: 449-56, 1996.
9. Leblhuber F, Walli J, Jellinger K, Tilz GP, Widner B, Laccone F and Fuchs D, Activated immune system in patients with Huntington's disease, Clin. Chem. Lab. Med. 36: 747-750, 1998.
10. Leblhuber F, Walli J, Demel U, Tilz GP, Widner B and Fuchs D, Increased serum neopterin concentrations in patients with Alzheimer's disease, Clin. Chem. Lab. Med. 37: 429-431, 1999.
11. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F and Cuny G, Lipid peroxidation and free radical scavengers in Alzheimers disease, 35: 275-282, 1989.
12. Toghi H, Abe T, Nakanishi M, Hamato F, Sasaki K and Takahashi S, Concentrations of α-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia, Neurosci. Lett. 174: 73-76, 1994.
13. Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC and Cayley ACD, Plasma concentrations of vitamins A and E and carotenoids in Alzheimers disease, Age Ageing, 21: 91-94, 1992.
14. Sano M, Emesto C, Thomas, RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer, E, Schneider, LS and Thai, LJ, for the members of the Alzheimers disease cooperative study. A controlled trial of seleginine, alpha-tocopherol, or both as treatment for Alzheimers disease, New Engl. J. Med. 336: 1216-1222, 1997.
15. Small GW, Treatment of Alzheimers disease: current approaches and promising developments, Am. J. Med. 104: 32s-38s, 1998.
16. McKhann G, Drachmann D, Folstein M, Katzmann R, Price D and Stadlan EM, Clinical Diagnosis of Alzheimer's disease Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease, Neurology 34: 934-944, 1984.
17. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H and Fuchs D, Cerebrospinal fluid neopterin concentrations in central nervous system infection. J. Infect. Dis. 168: 1285-1288, 1993.
18. Engelborghs S, De Brabander M, De Cree J, DHooge R, Geerts H, Verhaegen H and De Deyn PP, Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type, Neurochem. Int. 34: 523-530, 1999.
19. Leblhuber F, Walli J, Tilz GP, Jellinger K, Wachter H and Fuchs D, Increased serum neopterin concentrations in a patient with Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psych. 61: 211-212, 1996.
20. Widner B, Leblhuber F, Fuchs D, Increased neopterin concentrations in patients with Parkinsons disease. J. Neurol Neurosur Psychiatry, submitted for publication.
21. Westarp ME, Fuchs D, Bartmann P, Hoff-Jörgensen R, Clausen J, Wachter H and Kornhuber HH, Amyotrophic lateral sclerosis-an enigmatic disease with B-cellular and anti-retroviral immune responses, Eur. J. Med. 2: 327-332, 1993.
22. Solichova D, Melichar B, Svobodova I, Blaha V, Zadak Z., Fluorescence analysis of antioxidant vitamins and neopterin in nonagenarians, Biomed Chromat 13: 117-118, 1999.